home / stock / tlt / tlt message board
Subject | By | Source | When |
---|---|---|---|
PR Aug. 22, 2019 | frebeach | investorshub | 08/29/2019 4:34:56 PM |
PR July 31st, 2019. | frebeach | investorshub | 08/29/2019 4:31:12 PM |
Theralase Granted Notice of Acceptance for PhotoDynamic Compounds | frebeach | investorshub | 05/28/2019 3:54:41 PM |
Theralase Commences Phase II NMIBC Clinical Study | lonade | investorshub | 04/25/2019 11:32:52 AM |
Lightning Strikes Twice: A SECOND Patient Cancer-Free After | lonade | investorshub | 04/09/2019 12:33:43 PM |
June 30th, 2018 | frebeach | investorshub | 06/29/2018 6:42:00 AM |
Test | frebeach | investorshub | 06/29/2018 6:33:47 AM |
News, Short Squeeze, Breakout and More Instantly...
iShares 20+ Year Treasury Bond ETF Company Name:
TLT Stock Symbol:
NASDAQ Market:
TORONTO, ON / ACCESSWIRE / June 20, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...
TORONTO, ON / ACCESSWIRE / June 19, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their formu...
TORONTO, ON / ACCESSWIRE / April 14, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules and their form...